RecruitingObservational

Establishing a Tumor Registry of Patients With Mesonephric-like Adenocarcinoma (MLA)

NCT ID: NCT06377527Sponsor: M.D. Anderson Cancer CenterLast updated: 2025-12-26

Summary

To develop a database of medical information about patients with MLA in an effort to increase our understanding of the characteristics of MLA, which is the rarest form of endometrial carcinoma.

Detailed description

Primary Objectives 1\. To collect data on participants characteristics, disease characterization, pathology and molecular data, treatment, and outcomes for participants with gynecologic mesonephric-like adenocarcinoma (MLA). Secondary Objectives 1. To organize clinical information to support multifaceted queries of participant characteristics, treatment, and disease outcome data and to facilitate correlation of these characteristics with participant outcome. 2. To have a single data repository kept on a secure platform that will integrate clinical information and research findings and serve as an archive for future research.

Arms & interventions

Outcome measures

Primary

Tumor Registry
The goal of this data collection study is to develop a database (i.e. a registry/repository) of medical information about patients with MLA in an effort to increase our understanding of the characteristics of MLA, which is the rarest form of endometrial carcinoma.
Time frame: Through study completion; an average of 1 year

Eligibility criteria

Sex: AllAge: 18 Years and olderHealthy volunteers: No

Inclusion Criteria: 1. Adult patients over the age of 18. 2. Patients with a diagnosis of gynecologic mesonephric-like adenocarcinoma (MLA), mesonephric adenocarcinoma (MA), mesonephric carcinosarcoma, or mesonephric-like carcinosarcomas. 3. For patients who provide consent, they must speak and/or read English or Spanish. Exclusion Criteria: 1. Patients with other subtypes of EACs. 2. Patients who are considered cognitively impaired. Assessment will be obtained based on their need of a Legally Authorized Representative.

Study locations (1)

MD Anderson Cancer Center

Houston, Texas, 77030

Recruiting

Jeffrey How, MD · Contact

Jeffrey How, MD · Principal Investigator